KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Prepaid Assets (2018 - 2025)

Twist Bioscience (TWST) has disclosed Prepaid Assets for 6 consecutive years, with $13.5 million as the latest value for Q1 2023.

  • On a quarterly basis, Prepaid Assets rose 22.21% to $13.5 million in Q1 2023 year-over-year; TTM through Mar 2023 was $13.5 million, a 22.21% increase, with the full-year FY2022 number at $11.9 million, up 43.84% from a year prior.
  • Prepaid Assets was $13.5 million for Q1 2023 at Twist Bioscience, up from $11.9 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $13.5 million in Q1 2023 to a low of $2.6 million in Q3 2019.
  • A 5-year average of $7.9 million and a median of $8.1 million in 2020 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: decreased 25.18% in 2019, then soared 139.13% in 2020.
  • Twist Bioscience's Prepaid Assets stood at $5.7 million in 2019, then skyrocketed by 44.32% to $8.2 million in 2020, then grew by 21.78% to $10.0 million in 2021, then grew by 18.7% to $11.9 million in 2022, then grew by 13.34% to $13.5 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Prepaid Assets are $13.5 million (Q1 2023), $11.9 million (Q3 2022), and $12.3 million (Q2 2022).